Adena Healthcare Collaborative LLC

Transparency is one important aspect of patient centeredness and patient engagement in the Medicare Shared Savings Program (MSSP). We believe public reporting aids transparency and can promote more informed patient choice, provide feedback to stakeholders and providers, help improve quality and lower the cost of care, and improve oversight with respect to Adena Healthcare Collaborative, LLC's compliance with program requirements. This page provides important information for the public about Adena Healthcare Collaborative, LLC.

Providing the full spectrum of health care services within the Adena Health System is consistent with the stated purposes of the Medicare Shared Savings Program and the mission of Adena. In-network care coordination provides more efficient and effective care for our patients. As such, the governing body of Adena Healthcare Collaborative, LLC has determined that, in order to further the interests of the Accountable Care Organization (ACO) as a whole in meeting the objectives of the Medicare Shared Savings Program, it is reasonably necessary for Adena Healthcare Collaborative, LLC to include an in-network care coordination component and care coordination engagement factor in the Adena Medical Group. The in-network care coordination component and care coordination factor will be made available to all eligible Adena Healthcare Collaborative, LLC ACO participants and ACO providers and suppliers.

ACO Name and Location

Adena Healthcare Collaborative, LLC
272 Hospital Road
Chillicothe, Ohio 45601

ACO Primary Contact

Primary Contact Name	Bambi Huffman
Primary Contact Phone Number	740-542-4ACO (4226)
Primary Contact Email Address	bhuffman@adena.org

Organizational Information

ACO participants:

ACO Participants	ACO Participant in Joint Venture (Enter Y or N)
Adena Medical Group, LLC	N
Greenfield Area Medical Center	N
Pike Health Services Inc	N
Adena Health System	N

ACO governing body:

Member			Member's Voting Power	Membership Type	ACO Participant TIN Legal Business Name/DBA, if Applicable
Last Name	First Name	Title/Position	Member's Voting Power	Membership Type
Carlson	Lisa	Chairperson		ACO Particpant Representative	Adena Health System
Justice	Jay			ACO Particpant Representative	Adena Health System
Jetty, MD	Satish			ACO Particpant Representative	Adena Medical Group, LLC
Freeman, MD	Anthony			ACO Particpant Representative	Adena Medical Group, LLC
Kittaka, MD	Harry Takaji			ACO Particpant Representative	Adena Medical Group, LLC
Violette, MD	Robert			ACO Particpant Representative	Adena Medical Group, LLC
Edrington	Kathy			ACO Particpant Representative	Adena Health System
Beatty	William			Medicare Beneficiary

Key ACO clinical and administrative leadership:

Bambi Huffman	ACO Executive
Harry Kittaka	Medical Director
Tim Cahill	Compliance Officer
Rhett Holland	Quality Assurance/Improvement Officer

Associated committees and committee leadership:

Committee Name	Committee Leader Name and Position
Finance & Clincal Quality Committee	Dr. Robert Violette, Chair
Data & Analytics Committee	Jason Monroe & Rachel Collier, Co-Chairs

Types of ACO participants, or combinations of participants, that formed the ACO:

Partnerships or joint venture arrangements between hospitals and ACO professionals
Hospital employing ACO professionals
Critical Access Hospital (CAH) billing under Method II

Shared Savings and Losses

Amount of Shared Savings/Losses

First Agreement Period

Performance Year 2016, $4,453,320
Performance Year 2015, $2,551,721

Shared Savings Distribution

First Agreement Period

Performance Year 2016

Proportion invested in infrastructure: 28%
Proportion invested in redesigned care processes/resources: 8%
Proportion of distribution to ACO participants: 64%

Performance Year 2015

Proportion invested in infrastructure: 25% to cover start-up
Proportion invested in redesigned care processes/resources: n/a
Proportion of distribution to ACO participants: 75% (60% to PCPs & Specialists and 40% to Hospitals)

Quality Performance Results

2016 Quality Performance Results:

ACO#	Measure Name	Rate	ACO Mean
ACO-1	CAHPS: Getting Timely Care, Appointments, and Information	81.82	80.51
ACO-2	CAHPS: How Well Your Providers Communicate	94.62	93.01
ACO-3	CAHPS: Patients' Rating of Provider	94.13	92.25
ACO-4	CAHPS: Access to Specialists	82.59	83.49
ACO-5	CAHPS: Health Promotion and Education	57.35	60.32
ACO-6	CAHPS: Shared Decision Making	74.62	75.40
ACO-7	CAHPS: Health Status/Functional Status	69.97	72.30
ACO-34	CAHPS: Stewardship of Patient Resources	27.43	26.97
ACO-8	Risk-Standardized, All Condition Readmission	14.35	14.70
ACO-35	Skilled Nursing Facility 30-Day All-Cause Readmission Measure (SNFRM)	17.76	18.17
ACO-36	All-Cause Unplanned Admissions for Patients with Diabetes	39.42	53.20
ACO-37	All-Cause Unplanned Admissions for Patients with Heart Failure	62.18	75.23
ACO-38	All-Cause Unplanned Admissions for Patients with Multiple Chronic Conditions	48.2	59.81
ACO-9	Ambulatory Sensitive Conditions Admissions: Chronic Obstructive Pulmonary Disease or Asthma in Older Adults (AHRQ Prevention Quality Indicator (PQI) #5)	9.21	9.27
ACO-10	Ambulatory Sensitive Conditions Admissions: Heart Failure (AHRQ Prevention Quality Indicator (PQI) #8 )	9.38	14.53
ACO-11	Percent of PCPs who Successfully Meet Meaningful Use Requirements	100	82.72
ACO-39	Documentation of Current Medications in the Medical Record	99.83	87.54
ACO-13	Falls: Screening for Future Fall Risk	79.15	64.04
ACO-14	Preventive Care and Screening: Influenza Immunization	53.42	68.32
ACO-15	Pneumonia Vaccination Status for Older Adults	73.29	69.21
ACO-16	Preventive Care and Screening: Body Mass Index (BMI) Screening and Follow Up	47.94	74.45
ACO-17	Preventive Care and Screening: Tobacco Use: Screening and Cessation Intervention	97.72	90.98
ACO-18	Preventive Care and Screening: Screening for Clinical Depression and Follow-up Plan	47.25	53.63
ACO-19	Colorectal Cancer Screening	74.51	61.52
ACO-20	Breast Cancer Screening	85.9	67.61
ACO-21	Preventive Care and Screening: Screening for High Blood Pressure and Follow-up Documented	54.67	76.79
ACO-42	Statin Therapy for the Prevention and Treatment of Cardiovascular Disease	73.26	77.72
ACO-27	Diabetes Mellitus: Hemoglobin A1c Poor Control	15.61	18.24
ACO-41	Diabetes: Eye Exam	43.19	44.94
ACO-28	Hypertension (HTN): Controlling High Blood Pressure	72.11	70.69
ACO-30	Ischemic Vascular Disease (IVD): Use of Aspirin or Another Antithrombotic	91.82	85.05
ACO-31	Heart Failure (HF): Beta-Blocker Therapy for Left Ventricular Systolic Dysfunction (LVSD)	94.12	88.67
ACO-33	Angiotensin-Converting Enzyme (ACE) Inhibitor or Angiotensin Receptor Blocker (ARB) Therapy – for patients with CAD and Diabetes or Left Ventricular Systolic Dysfunction (LVEF<40%)	94.92	79.67

Please note, the ACO-40 Depression Remission at 12 months quality measure is not included in public reporting due to low samples.

For 2016 Quality Performance Results please visit: https://data.cms.gov/Special-Programs-Initiatives-Medicare-Shared-Savin/2016-Shared-Savings-Program-SSP-Accountable-Care-O/3jk5-q6dr/data
For 2015 Quality Performance Results please visit: https://data.cms.gov/Special-Programs-Initiatives-Medicare-Shared-Savin/Medicare-Shared-Savings-Program-Accountable-Care-O/x8va-z7cu

Note: In the Quality Performance Results file(s) above, search for “Adena Healthcare Collaborative, LLC” to view the quality performance results. This ACO can also be found by using the ACO ID A60506 in the public use files on data.cms.gov.

Payment Rule Waivers

No, our ACO does not use the SNF 3-Day Rule Waiver.